Annual report pursuant to Section 13 and 15(d)

Basis of Presentation and Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details)

v3.20.4
Basis of Presentation and Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Calculations of Net Loss Per Share (Details) - shares
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Anti-dilutive securities 2,023,000 1,174,000
Outstanding Options to Purchase Common Stock [Member]    
Anti-dilutive securities 1,780,000 931,000
Warrants to Purchase Common Stock [Member]    
Anti-dilutive securities 243,000 243,000